144 related articles for article (PubMed ID: 30196729)
1. Drugs that increase the risk of community-acquired pneumonia: a narrative review.
Liapikou A; Cilloniz C; Torres A
Expert Opin Drug Saf; 2018 Oct; 17(10):991-1003. PubMed ID: 30196729
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy and the risk for community-acquired pneumonia.
Gau JT; Acharya U; Khan S; Heh V; Mody L; Kao TC
BMC Geriatr; 2010 Jul; 10():45. PubMed ID: 20604960
[TBL] [Abstract][Full Text] [Related]
3. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
4. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis.
Lambert AA; Lam JO; Paik JJ; Ugarte-Gil C; Drummond MB; Crowell TA
PLoS One; 2015; 10(6):e0128004. PubMed ID: 26042842
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
6. Common medications that increase the risk for developing community-acquired pneumonia.
Restrepo MI; Mortensen EM; Anzueto A
Curr Opin Infect Dis; 2010 Apr; 23(2):145-51. PubMed ID: 20075727
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for community acquired pneumonia (CAP). A systematic review].
Kohlhammer Y; Schwartz M; Raspe H; Schäfer T
Dtsch Med Wochenschr; 2005 Feb; 130(8):381-6. PubMed ID: 15717247
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired pneumonia in the elderly.
Fung HB; Monteagudo-Chu MO
Am J Geriatr Pharmacother; 2010 Feb; 8(1):47-62. PubMed ID: 20226392
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).
Rivero-Calle I; Pardo-Seco J; Aldaz P; Vargas DA; Mascarós E; Redondo E; Díaz-Maroto JL; Linares-Rufo M; Fierro-Alacio MJ; Gil A; Molina J; Ocaña D; Martinón-Torres F;
BMC Infect Dis; 2016 Nov; 16(1):645. PubMed ID: 27821085
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired bacterial pneumonia in adult HIV-infected patients.
Cillóniz C; García-Vidal C; Moreno A; Miro JM; Torres A
Expert Rev Anti Infect Ther; 2018 Jul; 16(7):579-588. PubMed ID: 29976111
[TBL] [Abstract][Full Text] [Related]
12. Macrolides vs. quinolones for community-acquired pneumonia: meta-analysis of randomized controlled trials.
Skalsky K; Yahav D; Lador A; Eliakim-Raz N; Leibovici L; Paul M
Clin Microbiol Infect; 2013 Apr; 19(4):370-8. PubMed ID: 22489673
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for community-acquired pneumonia in the elderly.
Viasus D; Núñez-Ramos JA; Viloria SA; Carratalà J
Expert Opin Pharmacother; 2017 Jul; 18(10):957-964. PubMed ID: 28602108
[TBL] [Abstract][Full Text] [Related]
14. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients.
Dang TT; Majumdar SR; Marrie TJ; Eurich DT
Drugs Aging; 2015 Jan; 32(1):13-9. PubMed ID: 25491559
[TBL] [Abstract][Full Text] [Related]
15. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study.
Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J
Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
Xun X; Yin Q; Fu Y; He X; Dong Z
Ann Pharmacother; 2022 May; 56(5):524-532. PubMed ID: 34425689
[TBL] [Abstract][Full Text] [Related]
17. Acid-suppressive drugs and community-acquired pneumonia.
Rodríguez LA; Ruigómez A; Wallander MA; Johansson S
Epidemiology; 2009 Nov; 20(6):800-6. PubMed ID: 19797970
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study.
Chatterjee S; Carnahan RM; Chen H; Holmes HM; Johnson ML; Aparasu RR
J Am Geriatr Soc; 2016 Feb; 64(2):394-400. PubMed ID: 26889844
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis.
Raz-Pasteur A; Shasha D; Paul M
Int J Antimicrob Agents; 2015 Sep; 46(3):242-8. PubMed ID: 26092096
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Adjunctive Corticosteroids Therapy for Severe Community-Acquired Pneumonia in Adults: An Updated Systematic Review and Meta-Analysis.
Bi J; Yang J; Wang Y; Yao C; Mei J; Liu Y; Cao J; Lu Y
PLoS One; 2016; 11(11):e0165942. PubMed ID: 27846240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
